WHO ICTRP trial
"A study to test how well BI 3000202 is tolerated by people with type 1…
CTIS2024-514942-35-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2024-514942-35-00 |
|---|---|
| Public title | "A study to test how well BI 3000202 is tolerated by people with type 1 interferonopathies" |
| Scientific title | - 1509-0003 |
| Primary sponsor | Boehringer Ingelheim International GmbH |
| Secondary sponsors | Boehringer Ingelheim Espana S.A. |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Yes Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Spain;Portugal;Italy;France;Belgium;Germany |
| Conditions | Type 1 interferonopathies;Therapeutic area: Diseases [C] - Immune System Diseases [C20] |
| Registration date | Jun 11, 2024 |
| Target size | 9 |
| Secondary IDs | U1111-1309-4909 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: